Adverum Biotechnologies Inc (ADVM)
4.74
+0.04
(+0.85%)
USD |
NASDAQ |
Dec 20, 16:00
4.725
-0.02
(-0.32%)
After-Hours: 20:00
Adverum Biotechnologies Shareholders Equity (Quarterly): 144.12M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 218.73M |
| Cassava Sciences Inc | 166.64M |
| Regenxbio Inc | 301.42M |
| Editas Medicine Inc | 175.63M |
| Apellis Pharmaceuticals Inc | 237.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 234.38M |
| Total Liabilities (Quarterly) | 90.26M |
| Current Ratio | 5.824 |